Search Results - "Helfand, Alexander"

Refine Results
  1. 1
  2. 2

    Symptom burden and information needs in prostate cancer survivors: a case for tailored long‐term survivorship care by Bernat, Jennifer K., Wittman, Daniela A., Hawley, Sarah T., Hamstra, Daniel A., Helfand, Alexander M., Haggstrom, David A., Darwish‐Yassine, May, Skolarus, Ted A.

    Published in BJU international (01-09-2016)
    “…Objectives To determine the relationship between long‐term prostate cancer survivors’ symptom burden and information needs. Patients and Methods We used…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Cannabinoid Receptor 1 and Fatty Acid Amide Hydrolase Contribute to Operant Sensation Seeking in Mice by Helfand, Alexander I, Olsen, Christopher M, Hillard, Cecilia J

    “…A large body of evidence in humans and preclinical models supports a role for the endocannabinoid system in the proper execution of motivated or goal-directed…”
    Get full text
    Journal Article
  5. 5

    Griscelli Syndrome Type 3: Two New Cases and Review of the Literature by Nouriel, Ariella, Zisquit, Jonah, Helfand, Alexander M., Anikster, Yair, Greenberger, Shoshana

    Published in Pediatric dermatology (01-11-2015)
    “…A 3‐year‐old Arab boy with a history of hypoplastic left heart syndrome was referred to the pediatric dermatology clinic at Sheba Medical Center for evaluation…”
    Get full text
    Journal Article
  6. 6

    A quantitative comparison of the efferent projections of the anterior and posterior subdivisions of the medial amygdala in female mice by DiBenedictis, Brett T, Helfand, Alexander I, Baum, Michael J, Cherry, James A

    Published in Brain research (16-01-2014)
    “…Abstract In rodents, many aspects of sociosexual behavior are mediated by chemosignals released by opposite-sex conspecifics. These chemosignals are relayed…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Understanding Hospital Readmission Intensity after Radical Cystectomy by Skolarus, Ted A, Jacobs, Bruce L, Schroeck, Florian R, He, Chang, Helfand, Alexander M, Helm, Jonathan, Hu, Michael, Lavieri, Mariel, Hollenbeck, Brent K

    Published in The Journal of urology (01-05-2015)
    “…Purpose Hospital readmissions after radical cystectomy vary with respect to intensity in terms of impact on patients and health care systems. Therefore, we…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Circulating endoglin concentration is not elevated in chronic kidney disease by Charytan, David M, Helfand, Alexander M, MacDonald, Brian A, Cinelli, Angeles, Kalluri, Raghu, Zeisberg, Elisabeth M

    Published in PloS one (19-08-2011)
    “…Soluble endoglin, a TGF-β receptor, plays a key role in cardiovascular physiology. Whether circulating concentrations of soluble endoglin are elevated in CKD…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Segmental neurofibromatosis presenting with congenital excessive skin folds by Helfand, Alexander M, Nouriel, Ariella, Zisquit, Jonah, Barzilai, Aviv, Greenberger, Shoshana

    Published in Dermatology practical & conceptual (01-04-2015)
    “…Segmental neurofibromatosis (SNF) is a rare type of neurofibromatosis (NF-1) resulting from post-zygotic somatic mutations in the neurofibromin gene that leads…”
    Get full text
    Journal Article
  15. 15

    Inpatient outcomes of blinatumomab use: A national inpatient sample analysis by Bakalov, Veli, Tang, Amy, Helfand, Alexander M, Kancharla, Pragnan, White, Richard, Khattab, Ahmed, Alhousani, Mohammad, Samhouri, Yazan

    Published in Journal of clinical oncology (01-06-2022)
    “…e19021 Background: Blinatumomab, a bispecific (CD3/CD19) T-cell engager, is indicated for the treatment of acute lymphoblastic leukemia (ALL). The initial…”
    Get full text
    Journal Article
  16. 16

    SARS CoV-2 vaccine seroconversion and infection rates in patients on active cancer-directed therapy by Helfand, Alexander M, Bakalov, Veli, Friday, Andrew, Rodriguez, Robin Raquel, Walsh, Thomas, Mewawalla, Prerna, Samhouri, Yazan, Finley, Gene Grant

    Published in Journal of clinical oncology (01-06-2022)
    “…e18683 Background: Cancer-directed therapy, including cytotoxic chemotherapy and immunotherapy, is a known risk factor for decreased SARS-CoV-2 seroconversion…”
    Get full text
    Journal Article
  17. 17

    The rate of venous thromboembolism in patients with non-small cell lung cancer treated with chemotherapy or check point inhibitors by Singu, Sriharsha, Bakalov, Veli, Helfand, Alexander M, Kancharla, Pragnan, White, Richard, Khattab, Ahmed, Miller, Katherine, Samhouri, Yazan, Finley, Gene Grant

    Published in Journal of clinical oncology (01-06-2022)
    “…e21053 Background: Treatment with immune checkpoint inhibitors (CPI) targeting PD-1 or PD-L1 significantly improves progression free survival and overall…”
    Get full text
    Journal Article
  18. 18

    A national inpatient sample analysis for CAR-T cell therapy administration by Bakalov, Veli, Tang, Amy, Helfand, Alexander M, Kancharla, Pragnan, White, Richard, Khattab, Ahmed, Alhousani, Mohammad, Samhouri, Yazan

    Published in Journal of clinical oncology (01-06-2022)
    “…e19501 Background: Chimeric antigen receptor T-cell therapies (CAR-T) improve relapse free survival and durable remission rates in patients with…”
    Get full text
    Journal Article
  19. 19

    Patient Compliance With Maintenance Intravesical Therapy for Nonmuscle Invasive Bladder Cancer by Tapiero, Shlomi, Helfand, Alexander, Kedar, Daniel, Yossepowitch, Ofer, Nadu, Andrei, Baniel, Jack, Lifshitz, David, Margel, David

    Published in Urology (Ridgewood, N.J.) (01-08-2018)
    “…To assess patient adherence to intravesical instillation therapy for nonmuscle invasive urothelial carcinoma outside of clinical trials. We reviewed the…”
    Get full text
    Journal Article
  20. 20

    Association of Celiac Disease With Pembrolizumab by Sethi, Ashish, Helfand, Alexander, Balikani, Lame, Bunker, Mark, Finley, Gene

    Published in Curēus (Palo Alto, CA) (10-06-2021)
    “…Immune checkpoint inhibitors (ICIs) in the recent times have transformed the landscape of the management of many solid tumors. Unfortunately, many…”
    Get full text
    Journal Article